Eledon Pharmaceuticals, Inc. (ELDN) stock
ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.12−0.25 (-10.57%)
Close on Nov 13, 2026Market cap $171.87MP/E –Yield –
Eledon Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Eledon Pharmaceuticals's cash was $69.70M at Sep 30, 2026. For fiscal 2025 it was $133.30M, down 4.9% from the year before. Over ten years it grew 45.6% a year on average. The highest annual figure on record is $140.18M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $133.30M | -4.9% |
| FY2024 | Dec 31, 2024 | $140.18M | +174.3% |
| FY2023 | Dec 31, 2023 | $51.10M | -9.4% |
| FY2022 | Dec 31, 2022 | $56.41M | -33.5% |
| FY2021 | Dec 31, 2021 | $84.83M | -25.7% |
| FY2020 | Dec 31, 2020 | $114.20M | +1199.0% |
| FY2019 | Dec 31, 2019 | $8.79M | -32.2% |
| FY2018 | Dec 31, 2018 | $12.97M | -25.0% |
| FY2017 | Dec 31, 2017 | $17.30M | +1449.1% |
| FY2016 | Dec 31, 2016 | $1.12M | -64.1% |
| FY2015 | Dec 31, 2015 | $3.11M | -97.0% |
| FY2014 | Dec 31, 2014 | $105.26M | +231.5% |
| FY2013 | Dec 31, 2013 | $31.75M | +171.6% |
| FY2012 | Dec 31, 2012 | $11.69M | +418.9% |
| FY2011 | Dec 31, 2011 | $2.25M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $69.70M | -25.4% |
| Q2 FY2026 | Jun 30, 2026 | $88.80M | -17.5% |
| Q1 FY2026 | Mar 31, 2026 | $111.10M | -11.0% |
| Q4 FY2025 | Dec 31, 2025 | $133.30M | -4.9% |
| Q3 FY2025 | Sep 30, 2025 | $93.40M | +19.4% |
| Q2 FY2025 | Jun 30, 2025 | $107.60M | +28.7% |
| Q1 FY2025 | Mar 31, 2025 | $124.90M | +191.1% |
| Q4 FY2024 | Dec 31, 2024 | $140.18M | +174.3% |
| Q3 FY2024 | Sep 30, 2024 | $78.20M | +31.2% |
| Q2 FY2024 | Jun 30, 2024 | $83.60M | +17.1% |
| Q1 FY2024 | Mar 31, 2024 | $42.90M | -7.7% |
| Q4 FY2023 | Dec 31, 2023 | $51.10M | -9.4% |
| Q3 FY2023 | Sep 30, 2023 | $59.60M | -9.5% |
| Q2 FY2023 | Jun 30, 2023 | $71.40M | +1.3% |
| Q1 FY2023 | Mar 31, 2023 | $46.49M | -39.4% |
| Q4 FY2022 | Dec 31, 2022 | $56.41M | -33.5% |
| Q3 FY2022 | Sep 30, 2022 | $65.89M | -29.9% |
| Q2 FY2022 | Jun 30, 2022 | $70.46M | -30.3% |
| Q1 FY2022 | Mar 31, 2022 | $76.68M | -29.4% |
| Q4 FY2021 | Dec 31, 2021 | $84.83M | -25.7% |
| Q3 FY2021 | Sep 30, 2021 | $94.04M | -17.8% |
| Q2 FY2021 | Jun 30, 2021 | $101.13M | +1054.0% |
| Q1 FY2021 | Mar 31, 2021 | $108.58M | +821.3% |
| Q4 FY2020 | Dec 31, 2020 | $114.20M | +1199.0% |
| Q3 FY2020 | Sep 30, 2020 | $114.46M | +958.5% |
| Q2 FY2020 | Jun 30, 2020 | $8.76M | -36.0% |
| Q1 FY2020 | Mar 31, 2020 | $11.79M | -14.0% |
| Q4 FY2019 | Dec 31, 2019 | $8.79M | -32.2% |
| Q3 FY2019 | Sep 30, 2019 | $10.81M | -33.8% |
| Q2 FY2019 | Jun 30, 2019 | $13.70M | -28.6% |
| Q1 FY2019 | Mar 31, 2019 | $13.70M | -39.2% |
| Q4 FY2018 | Dec 31, 2018 | $12.97M | -25.0% |
| Q3 FY2018 | Sep 30, 2018 | $16.32M | -14.8% |
| Q2 FY2018 | Jun 30, 2018 | $19.19M | -15.0% |
| Q1 FY2018 | Mar 31, 2018 | $22.52M | +3446.9% |
| Q4 FY2017 | Dec 31, 2017 | $17.30M | +1449.1% |
| Q3 FY2017 | Sep 30, 2017 | $19.16M | – |
| Q2 FY2017 | Jun 30, 2017 | $22.58M | – |
| Q1 FY2017 | Mar 31, 2017 | $635.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $1.12M | – |
See a number that looks wrong?